Detailed information for compound 792102

Basic information

Technical information
  • TDR Targets ID: 792102
  • Name: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-N-prop ylpentanamide
  • MW: 381.33 | Formula: C17H21BrN2OS
  • H donors: 0 H acceptors: 2 LogP: 5.26 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCN(c1scc(n1)c1ccc(cc1)Br)C(=O)CCCC
  • InChi: 1S/C17H21BrN2OS/c1-3-5-6-16(21)20(11-4-2)17-19-15(12-22-17)13-7-9-14(18)10-8-13/h7-10,12H,3-6,11H2,1-2H3
  • InChiKey: QLGZLQHSZSBVCE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[4-(4-bromophenyl)thiazol-2-yl]-N-propyl-pentanamide
  • N-[4-(4-bromophenyl)-2-thiazolyl]-N-propylpentanamide
  • N-[4-(4-bromophenyl)thiazol-2-yl]-N-propyl-valeramide
  • N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-N-propyl-pentanamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium vivax thioredoxin reductase, putative 0.005 0.2539 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0877 0.3702
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.1707 0.7204
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0017 0.0312 0.5
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Trypanosoma brucei dihydrolipoamide dehydrogenase, point mutation 0.0017 0.0312 0.0408
Trypanosoma brucei dihydrolipoyl dehydrogenase 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.1047 0.4418
Mycobacterium tuberculosis Probable reductase 0.0115 0.6905 0.8837
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Trichomonas vaginalis mercuric reductase, putative 0.0017 0.0312 0.1316
Trichomonas vaginalis PIKK family atypical protein kinase 0.0029 0.1066 0.4499
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0128 0.7773 1
Trypanosoma brucei trypanothione reductase 0.005 0.2539 1
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0017 0.0312 0.0408
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0017 0.0312 0.0408
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0048 0.237 0.9272
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0017 0.0312 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Treponema pallidum NADH oxidase 0.0017 0.0312 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0029 0.1066 0.4499
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.237 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.237 1
Plasmodium falciparum glutathione reductase 0.005 0.2539 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0048 0.237 0.9272
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0048 0.237 0.9272
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.088 0.3713
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0115 0.6905 0.8837
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0048 0.237 0.9272
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.1707 0.7204
Toxoplasma gondii thioredoxin reductase 0.005 0.2539 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.1707 0.7204
Leishmania major acetoin dehydrogenase e3 component-like protein 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.088 0.3713
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.1707 0.7204
Trypanosoma cruzi trypanothione reductase, putative 0.005 0.2539 1
Brugia malayi glutathione reductase 0.005 0.2539 1
Loa Loa (eye worm) glutathione reductase 0.005 0.2539 1
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0128 0.7773 1
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.005 0.2539 0.2985
Trichomonas vaginalis PIKK family atypical protein kinase 0.0029 0.1066 0.4499
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0038 0.171 0.6429
Trypanosoma cruzi trypanothione reductase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.088 0.3713
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0048 0.237 0.9272
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0877 0.3702
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0115 0.6905 0.8837
Plasmodium vivax glutathione reductase, putative 0.005 0.2539 1
Toxoplasma gondii target of rapamycin (TOR), putative 0.0036 0.154 0.5514
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis glutathione reductase, putative 0.0017 0.0312 0.1316
Echinococcus multilocularis thioredoxin glutathione reductase 0.005 0.2539 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Plasmodium falciparum thioredoxin reductase 0.005 0.2539 1
Giardia lamblia GTOR 0.0048 0.237 1
Leishmania major 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein 0.0017 0.0312 0.0408
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Loa Loa (eye worm) thioredoxin reductase 0.005 0.2539 1
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0023 0.0663 0.1919
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.0217 0.0916
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Leishmania major trypanothione reductase 0.005 0.2539 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0017 0.0312 0.5
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0115 0.6905 0.8837
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0048 0.237 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.0217 0.0916
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0017 0.0312 0.0408
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0017 0.0312 0.5
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0048 0.237 0.9272
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.1047 0.4418
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0312 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0877 0.3702
Trichomonas vaginalis PIKK family atypical protein kinase 0.0031 0.1234 0.5205
Trichomonas vaginalis PIKK family atypical protein kinase 0.0041 0.1896 0.8002
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0017 0.0312 0.0408
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0115 0.6905 0.8837
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0048 0.237 0.9272
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0017 0.0312 0.0408
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0017 0.0312 0.0408
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0017 0.0312 0.0097
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.237 1
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0038 0.171 0.6429
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.0217 0.0916
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.0217 0.0916
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0312 0.5
Echinococcus granulosus thioredoxin glutathione reductase 0.005 0.2539 1
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0128 0.7773 1
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0048 0.237 0.2201
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.002 0.0476 0.1116
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0048 0.237 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.1304 0.5501
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0048 0.237 0.9272
Mycobacterium tuberculosis Probable dehydrogenase 0.0115 0.6905 0.8837
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0048 0.237 0.9272
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.088 0.3713
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0048 0.237 0.9272
Mycobacterium tuberculosis Probable oxidoreductase 0.0128 0.7773 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.0217 0.0916
Trypanosoma cruzi target of rapamycin kinase 3 0.0038 0.171 0.6429
Brugia malayi Thioredoxin reductase 0.005 0.2539 1
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0312 0.0408
Trichomonas vaginalis PIKK family atypical protein kinase 0.0036 0.154 0.6498
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.1707 0.7204

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.